RLS Foundation Research Grant

Issue Date: December 8, 2023
Letter of Intent Due Date: January 26, 2024
Invitations to Submit Full Application Notification: By February 16, 2024
Application Due Date: April 5, 2024
Grant Selection Notification: By July 1, 2024
Amount of Grant: $50,000 for 1 year

The AASM Foundation is partnering with the Restless Leg Syndrome Foundation (RLS Foundation) to co-fund basic and clinical restless legs syndrome (RLS) research. For this new round of funding, the primary research priorities are:

  • Neurobiological interaction: Elucidate the points of interaction between RLS-relevant neurotransmitters, neuronal pathways, and iron deficiency.
  • Pharmacologic treatments: Elucidate effects of novel pharmacological approaches on RLS.
  • Clinical Practice: research based on innovations in patient care delivery including but not limited to population health programs, technology-enabled healthcare delivery (i.e.; telemedicine) and public health initiatives.
  • Other topics: Other research areas accepted for funding consideration.

Grant proposals of a 1 year-duration, with funding levels of up to $50,000 (including 8% for F&A costs), based on the number of funded applications. A renewal or extension of a proposed project may be considered, but this extension would be subject to the regular competitive approval process for year 2.

Eligibility: All institutions within the United States, Canada, and other countries where supervision of grant administration is possible are eligible.

Human Subject Protection: Approval by the institution’s human investigation committee is necessary for all projects that involve human subjects.

Recombinant DNA Research and Animal Welfare: The RLS Foundation has adopted the regulations pertaining to these areas, as established by the US Public Health Service.

Multiple Awards: Individual investigators may receive a maximum of one RLSF grant award of any kind in a given year.